1YBottom 25% of the group
Rank 36 of 41 funds
Return −17.44%
1Y returns of 41 funds in the China Equity - A Shares group, sorted from highest to lowest. This fund ranks 36No. 1 is TCHSTRATEGY +0.80%
Eastspring China A Active Fund
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
ES-CHINAA-SSF invests through the master fund UBS (Lux) IS - China A Opportunity 100.84%
This fundES-CHINAA-SSFThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
NAURA Technology Group Co Lt… 002371.SZ9.38%
Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per UBS Asset Management fact sheet · Country inferred from the name of a single-country fund
Over the past year it was in the bottom 25% of its group; there is no rank for a longer period yet
No. 1 is TCHSTRATEGY +0.80%
Each bar is one fund in the AIMC China Equity - A Shares group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | MAX |
|---|---|---|---|---|---|---|---|
| −18.00% | −0.07% | −3.60% | −11.12% | −16.33% | −19.03% | −17.44% | −10.84% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar | Apr | May | Jun |
|---|
Largest drawdown in the selected period −23.12% Previous peak 13 May 2026 (NAV 11.4615) → Trough 30 Oct 2026 (NAV 8.8115) · Not back to the previous peak as of 3 Nov 2026
Currently −22.51% from the peak NAV of 11.4615 (13 May 2026)
Over 1 year, ES-CHINAA-SSF returned -0.89 per unit of volatility, ranking 21 of 25 funds · The highest is TCHSTRATEGY (0.03)
กองทุนจะเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศเพียงกองเดียว คือ กองทุน UBS (Lux) IS - China A Opportunity (กองทุนหลัก) ในหน่วยลงทุนชนิด Class I-A2-acc ซึ่งเป็น Class ที่เสนอขายผู้ลงทุนสถาบัน ไม่มีนโยบายจ่ายเงินปันผล ในอัตราส่วนโดยเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80… Its largest holdings are UBS Lux Investment Sicav II - China A Opportunity 100.84% (fact sheet 30 Sep 2026)
Risk level 6 of 8 (High risk). Since 17 Jun 2025, its NAV has fallen as much as −23.12% from its peak.
Actual total expense ratio (TER) 1.03% a year, against a ceiling of 2.51%. Management fee 1.61%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1 THB, subsequent purchases 1 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 98.25% of the value of its foreign investments was hedged
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · ES-CHINAA-SSF: no dividends, TER 1.03% · ES-CHINAA-A: no dividends, TER 1.03% · ES-CHINAA-D: see the conditions in the prospectus · ES-CHINAA-E: see the conditions in the prospectus · ES-CHINAA-I: see the conditions in the prospectus · ES-CHINAA-P: see the conditions in the prospectus · ES-CHINAA-R: see the conditions in the prospectus · ES-CHINAA-S: see the conditions in the prospectus
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Fuyao Glass Industry Group 6006606.25%
Kweichow Moutai 6005196.05%
Ping An Insurance (Group) Co… 023185.14%
Jiangsu Hengrui Pharmaceutic… 600276.SS4.03%NAURA Technology Group Co Lt… 002371.SZMobile networks, internet and software
CATL 300750Makes lithium-ion batteries for many electric vehicle brands, as well as energy storage systems
Contract research and drug manufacturing for drug companies worldwide
Mobile networks, internet and software
Collects insurance premiums, then invests the money
Jiangsu Hengrui Pharmaceutic… 600276.SSHospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (100.84% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 30 Sep 2026 · fact sheet from UBS Asset Management · Illustrations are for explanation only, not individual stock recommendations
| Jul |
|---|
| Aug |
|---|
| Sep |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Full year |
|---|
| 2026 | −0.2 | +0.6 | −5.7 | +7.0 | −1.0 | +1.9 | −2.5 | −0.7 | −6.7 | −11.8 | +0.8 | · | −18.0* |
| 2025 | · | · | · | · | · | +0.4 | +2.1 | +5.7 | +3.1 | −2.8 | −1.0 | +1.3 | +8.7* |